 
| In ZINC since | Heavy atoms | Benign functionality | 
|---|---|---|
| August 17th, 2004 | 23 | Yes | 
Popular Name: N-(2-furylmethyl)-4-(2-methylbenzoyl)-1H-pyrrole-2-carboxamide N-(2-furylmethyl)-4-(2-methylben…
Find On: PubMed — Wikipedia — Google
CAS Number: 478249-26-2
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL | 
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 2.73 | 6.65 | -16.85 | 2 | 5 | 0 | 75 | 308.337 | 5 | ↓ | 
| Note Type | Comments | Provided By | 
|---|---|---|
| melting_point | 171 - 173 | KeyOrganics | 
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type | 
|---|---|---|---|---|---|
| MK08-1-E | Mitogen-activated Protein Kinase 8 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 10000 | 0.30 | Binding ≤ 10μM | 
| MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6310 | 0.32 | Binding ≤ 10μM | 
| MK14-2-E | MAP Kinase P38 Alpha (cluster #2 Of 3), Eukaryotic | Eukaryotes | 631 | 0.38 | Binding ≤ 10μM | 
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type | 
|---|---|---|---|---|---|
| MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 251.188643 | 0.40 | Binding ≤ 1μM | 
| MK08_HUMAN | P45983 | C-Jun N-terminal Kinase 1, Human | 10000 | 0.30 | Binding ≤ 10μM | 
| MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 251.188643 | 0.40 | Binding ≤ 10μM | 
| MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 6309.57344 | 0.32 | Binding ≤ 10μM | 
| Description | Species | 
|---|---|
| activated TAK1 mediates p38 MAPK activation | |
| Activation of BIM and translocation to mitochondria | |
| Activation of BMF and translocation to mitochondria | |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
| Activation of the AP-1 family of transcription factors | |
| ADP signalling through P2Y purinoceptor 1 | |
| CDO in myogenesis | |
| DSCAM interactions | |
| ERK/MAPK targets | |
| FCERI mediated MAPK activation | |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
| KSRP destabilizes mRNA | |
| NOD1/2 Signaling Pathway | |
| NRAGE signals death through JNK | |
| NRIF signals cell death from the nucleus | |
| Oxidative Stress Induced Senescence | |
| p38MAPK events | |
| Platelet sensitization by LDL | |
| VEGFA-VEGFR2 Pathway | 
No pre-computed analogs available. Try a structural similarity search.